At an Extraordinary General Meeting of Diamyd Medical AB on April 22, 2013, it
was decided to change the Company’s name to Mertiva AB. The web address to
Mertiva is www.mertiva.se.
The change of name to Mertiva AB is part of the restructuring of the Diamyd
Group which was decided at an Extraordinary General Meeting on April 22, 2013.
The restructuring also entails distributing the subsidiary Diamyd Therapeutics
AB with the diabetes operations to the shareholders and that the spun out
company assumes the name Diamyd Medical AB and the web address www.diamyd.com.
Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small
Cap) in Stockholm (ticker: DIAM B). The ticker will be changed as soon as
possible, to reflect the change of name.
For more information, please contact:
info@mertiva.se
About Mertiva
Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid
assets and holdings in Protein Sciences Corporation and Mercodia AB.
Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small
Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY)
administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).
More information can be found at www.mertiva.se
This information is disclosed in accordance with the Swedish Securities Markets
Act, the Swedish Financial Instruments Trading Act, or the requirements stated
in the listing agreements.
Mertiva AB (publ)
Karlavägen 108, SE-115 26 Stockholm, Sweden.
E-mail: info@mertiva.com. Reg. no: 556530-1420
